Pharmacophore modeling of cytochromes P450
- 6 February 2002
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 54 (3) , 367-383
- https://doi.org/10.1016/s0169-409x(02)00009-1
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Sterol 14-Demethylase P450 (CYP51) Provides a Breakthrough for the Discussion on the Evolution of Cytochrome P450 Gene SuperfamilyBiochemical and Biophysical Research Communications, 2000
- Arginines 97 and 108 in CYP2C9 Are Important Determinants of the Catalytic FunctionBiochemical and Biophysical Research Communications, 2000
- Three-Dimensional Quantitative Structure−Activity Relationship (QSAR) and Receptor Mapping of Cytochrome P-45014αDM Inhibiting Azole Antifungal AgentsJournal of Chemical Information and Computer Sciences, 1999
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- Interaction of Sulfaphenazole Derivatives with Human Liver Cytochromes P450 2C: Molecular Origin of the Specific Inhibitory Effects of Sulfaphenazole on CYP 2C9 and Consequences for the Substrate Binding Site Topology of CYP 2C9Biochemistry, 1996
- Comparative Molecular Field Analysis of Compounds with CYP2A5 Binding AffinityQuantitative Structure-Activity Relationships, 1995
- The P450 Superfamily: Update on New Sequences, Gene Mapping, Accession Numbers, Early Trivial Names of Enzymes, and NomenclatureDNA and Cell Biology, 1993
- The Human Hepatic Cytochromes P450 Involved in Drug MetabolismCritical Reviews in Toxicology, 1992
- The active site of cytochrome P-450 nifedipine oxidase: a model-building studyJournal of Molecular Graphics, 1989
- The molecular mechanisms of two common polymorphisms of drug oxidation-evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidationXenobiotica, 1986